Ten to twelve weeks-old WT and DKO HLA-DQ8 transgenic mice of either sex subcutaneously implanted with 7-day mini osmotic pumps delivering either PBS or SEB (50 μg) were killed 7 days after implantation. (i) Formalin-fixed, paraffin-embedded tissue sections from mice treated as above were stained with H&E and evaluated microscopically. Representative images are shown. Panels A, B and C – Respective lung, kidney and liver sections from WT HLA-DQ8 transgenic mice challenged with PBS. Panels D, E and F – Respective lung, kidney and liver sections from WT HLA-DQ8 transgenic mice challenged with SEB. Panels G, H and I – Respective lung, kidney and liver sections from DKO HLA-DQ8 transgenic mice challenged with PBS. Panels J, K and L – Respective lung, kidney and liver sections from DKO HLA-DQ8 transgenic mice challenged with SEB. (ii) Frozen liver sections from WT HLA-DQ8 transgenic mice challenged with PBS (panel M) or SEB (panel N) and liver sections from DKO HLA-DQ8 transgenic mice challenged with PBS (panel M) or SEB (panel N) were stained with FITC-conjugated anti-CD3 antibodies. Representative images from PBS and SEB treated mice are shown. (iii) Mean organ histopathology scores from WT and DKO HLA-DQ8 transgenic mice challenged with PBS or SEB was determined as described in methods section. Mean data from 4-5 mice/group. * p<0.05 when compared to respective PBS-treated mice and NS – Not significant.